Transcriptomics and proteomics in human African trypanosomiasis: Current status and perspectives

Journal of Proteomics

Volumn 74, Issue 9, 2011, Pages 1625-1643

  Geiger, Anne ^a   Simo, Gustave ^b   Grébaut, Pascal ^a   Peltier, Jean Benoît ^c   Cuny, Gérard ^a   Holzmuller, Philippe ^a  

^a Institut de recherche pour le développement   (France)

^b UNIVERSITY OF DSCHANG   (Cameroon)

^c CEMAGREF   (France)

Author keywords

Human; Human African trypanosomiasis; Interactions; Molecular targets; New diagnostic tools; New therapeutic tools; Proteomics; Transcriptomics; Trypanosome; Tsetse fly

Indexed keywords

EFLORNITHINE; FEXINIDAZOLE; MELARSOPROL; MESSENGER RNA; NIFURTIMOX; PENTAMIDINE; SURAMIN;

AFRICAN TRYPANOSOMIASIS; ANEMIA; BLEEDING; BRAIN DISEASE; DIARRHEA; DISEASE TRANSMISSION; DNA SEQUENCE; DRUG INDUCED HEADACHE; EPIDEMIC; FEVER; GENE CONTROL; GENE EXPRESSION; HAIR LOSS; HEARING LOSS; HUMAN; INFECTION RISK; LEUKOPENIA; LIFE CYCLE; MICROARRAY ANALYSIS; NAUSEA; NEUROLOGICAL COMPLICATION; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SEROLOGY; STOMACH PAIN; THROMBOCYTOPENIA; TRANSCRIPTOMICS; TRYPANOSOMA; TRYPANOSOMA BRUCEI; VOMITING; WEAKNESS;

ANIMALS; GENE EXPRESSION PROFILING; HOST-PARASITE INTERACTIONS; HUMANS; PARASITIC DISEASES; PROTEOMICS; TRYPANOSOMIASIS, AFRICAN;

GLOSSINA (GENUS); PROTOZOA; TRYPANOSOMA BRUCEI;

EID: 80051665422     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.01.016     Document Type: Review

References (150)

1. Reinhardt E. Travailler ensemble: la mouche tsé-tsé et la pauvreté rurale [Internet]. Available from, Chronique ONU 2002;ONU Editor-September 02. http://www.un.org/french/pubs/chronique/2002/numero2/0202p17_la_mouche_tsetse.html.
2. Atkins J. The Navy, Surgeon; 1734.
3. Louis F.J., Simarro P.P., Lucas P. Maladie du sommeil: cent ans d'évolution des stratégies de lutte. Bull Soc Pathol Exot 2002, 95:331-336.
4. WHO Control and surveillance of African trypanosomiasis. WHO Technical Report Series 1998, 881.
5. Cattand P., Jannin J., Lucas P. Sleeping sickness surveillance: an essential step towards elimination. Trop Med Int Health 2001, 6:348-361.
6. Odiit M., Shaw A., Welburn S.C., Fèvre E.M., Coleman P.G., McDermott J.J. Assessing the patterns of health-seeking behaviour and awareness among sleeping-sickness patients in eastern Uganda. Ann Trop Med Parasitol 2004, 98:339-348.
7. WHO African trypanosomiasis (sleeping sickness). WHO Technical Report Series 2010, 259.
8. Welburn S.C., Maudlin I., Simarro P.P. Controlling sleeping sickness-a review. Parasitology 2009, 136:1943-1949.
9. Hotez P.J., Fenwick A., Savioli L., Molyneux D.H. Rescuing the bottom billion through control of neglected tropical diseases. Lancet 2009, 373:1570-1575.
10. Fèvre E.M., Wissmann B.V., Welburn S.C., Lutumba P. The burden of human African trypanosomiasis. PLoS Negl Trop Dis 2008, 2:e333.
11. Njiokou F., Laveissière C., Simo G., Nkinin S., Grébaut P., Cuny G., et al. Wild fauna as a probable animal reservoir for Trypanosoma brucei gambiense in Cameroon. Infect Genet Evol 2006, 6:147-153.
12. Matthews K.R. The developmental cell biology of Trypanosoma brucei. J Cell Sci 2005, 118:283-290.
13. Barry J.D., McCulloch R. Antigenic variation in trypanosomes: enhanced phenotypic variation in a eukaryotic parasite. Adv Parasitol 2001, 49:1-70.
14. Dumas M., Bouteille B. Human African trypanosomiasis. C R Seances Soc Biol Fil 1996, 190:395-408.
15. Grab D.J., Kennedy P.G. Traversal of human and animal trypanosomes across the blood-brain barrier. J Neurovirol 2008, 14:344-351.
16. Nikolskaia O.V., De A.Lima A.P., Kim Y.V., Lonsdale-Eccles J.D., Fukuma T., Scharfstein J., et al. Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease. J Clin Invest 2008, 118:1974.
17. Rodgers J. Trypanosomiasis and the brain. Parasitology 2010, 137:1995-2006.
18. Garcia A., Courtin D., Solano P., Koffi M., Jamonneau V. Human African trypanosomiasis: connecting parasite and host genetics. Trends Parasitol 2006, 22:405-409.
19. Truc P., Formenty P., Diallo P.B., Komoin-Oka C., Lauginie F. Confirmation of two distinct classes of zymodemes of Trypanosoma brucei infecting man and wild mammals in Cote d'Ivoire: suspected difference in pathogenicity. Ann Trop Med Parasitol 1997, 91:951-956.
20. Smith D.H., Bailey J.W. Human African trypanosomiasis in south-eastern Uganda: clinical diversity and isoenzyme profiles. Ann Trop Med Parasitol 1997, 91:851-856.
21. Maclean L., Chisi J.E., Odiit M., Gibson W.C., Ferris V., Picozzi K., et al. Severity of human African trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile. Infect Immun 2004, 72:7040-7044.
22. Courtin D., Berthier D., Thevenon S., Dayo G.K., Garcia A., Bucheton B. Host genetics in African trypanosomiasis. Infect Genet Evol 2008, 8:229-238.
23. Sbicego S., Vassella E., Kurath U., Blum B., Roditi I. The use of transgenic Trypanosoma brucei to identify compounds inducing the differentiation of bloodstream forms to procyclic forms. Mol Biochem Parasitol 1999, 104:311-322.
24. Van Den Abbeele J., Claes Y., Van Bockstaele D., Le Ray D., Coosemans M. Trypanosoma brucei spp. development in the tsetse fly: characterization of the post-mesocyclic stages in the foregut and proboscis. Parasitology 1999, 118:469-478.
25. Roditi I., Schwarz H., Pearson T.W., Beecroft R.P., Liu M.K., Richardson J.E., et al. Procyclin gene expression and loss of the variant surface glycoprotein during differentiation of Trypanosoma brucei. J Cell Biol 1989, 108:737-746.
26. Welburn S.C., Maudlin I. Tsetse-trypanosome interactions: rites of passage. Parasitol Today 1999, 15:399-403.
27. Hao Z., Kasumba I., Lehane M.J., Gibson W.C., Kwon J., Aksoy S. Tsetse immune responses and trypanosome transmission: implications for the development of tsetse-based strategies to reduce trypanosomiasis. Proc Natl Acad Sci USA 2001, 98:12648-12653.
28. MacLeod E.T., Maudlin I., Darby A.C., Welburn S.C. Antioxidants promote establishment of trypanosome infections in tsetse. Parasitology 2007, 134:827-831.
29. Maudlin I., Welburn S.C. Maturation of trypanosome infections in tsetse. Exp Parasitol 1994, 79:202-205.
30. Aksoy S. Tsetse-a haven for microorganisms. Parasitol Today 2000, 16:114-118.
31. Geiger A., Fardeau M.L., Grebaut P., Vatunga G., Josénando T., Herder S., et al. First isolation of Enterobacter, Enterococcus, and Acinetobacter spp. as inhabitants of the tsetse fly (Glossina palpalis palpalis) midgut. Infect Genet Evol 2009, 9:1364-1370.
32. Geiger A., Fardeau M.L., Falsen E., Ollivier B., Cuny G. Serratia glossinae sp. nov., isolated from the midgut of the tsetse fly Glossina palpalis gambiensis. Int J Syst Evol Microbiol 2010, 60:1261-1265.
33. Farikou O., Njiokou F., Mbida Mbida J.A., Njitchouang G.R., Nana Djeunga H., Asonganyi T., et al. Tripartite interactions between tsetse flies, Sodalis glossinidius and trypanosomes-an epidemiological approach in two historical human African trypanosomiasis foci in Cameroon. Infect Genet Evol 2010, 10:115-121.
34. Magnus E., Vervoort T., Van Meirvenne N. A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. b. gambiense trypanosomiasis. Ann Soc Belg Med Trop 1978, 58:169-176.
35. Lutumba P., Robays J., Miaka C., Kande V., Mumba D., Büscher P., et al. Validity, cost and feasibility of the mAECT and CTC confirmation tests after diagnosis of African of sleeping sickness. Trop Med Int Health 2006, 11:470-478.
36. Truc P., Jamonneau V., N'Guessan P., Diallo P.B., Garcia A. Parasitological diagnosis of African trypanosomiasis: a comparison of the QBC and miniature anion-exchange centrifugation techniques. Trans R Soc Trop Med Hyg 1998, 92:288-289.
37. Dukes P., Gibson W.C., Gashumba J.K., Hudson K.M., Bromidge T.J., Kaukus A., et al. Absence of the LiTat 1.3 (CATT antigen) gene in Trypanosoma brucei gambiense stocks from Cameroon. Acta Trop 1992, 51:123-134.
38. Diallo P.B., Truc P., Méda H.A., Kamenan A. Diagnostic sérologique de la trypanosomiase humaine africaine à Trypanosoma brucei gambiense. 1. Obtention et utilisation d'antigènes bruts dans les tests ELISA et d'agglutination au latex. Bull Soc Pathol Exot 1996, 89:262-268.
39. Bisser S., Bouteille B., Sarda J., Stanghellini A., Ricard D., Jauberteau M.O., et al. Apport des examens biochimiques dans le diagnostic de la phase nerveuse de la Trypanosomose humaine africaine. Bull Soc Pathol Exot 1997, 90:321-326.
40. Lejon V., Büscher P. Stage determination and follow-up in sleeping sickness. Med Trop 2001, 61:355-360.
41. Papadopoulos M.C., Abel P.M., Agranoff D., Stich A., Tarelli E., Bell B.A., et al. A novel and accurate diagnostic test for human African trypanosomiasis. Lancet 2004, 363:1358-1363.
42. Lejon V., Legros D., Richer M., Ruiz J.A., Jamonneau V., Truc P., et al. IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test. Trop Med Int Health 2002, 7:685-692.
43. Courtioux B., Bisser S., M'belesso P., Ngoungou E., Girard M., Nangouma A., et al. Dot enzyme-linked immunosorbent assay for more reliable staging of patients with Human African Trypanosomiasis. J Clin Microbiol 2005, 43:4789-4795.
44. Lejon V., Jamonneau V., Solano P., Atchade P., Mumba D., Nkoy N., et al. Detection of trypanosome-specific antibodies in saliva, towards non-invasive serological diagnosis of sleeping sickness. Trop Med Int Health 2006, 11:620-627.
45. Barrett M.P., Boykin D.W., Brun R., Tidwell R.R. Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. Br J Pharmacol 2007, 152:1155-1171.
46. Burri C., Brun R. Eflornithine for treatment of human African trypanosomiasis. Parasitol Res 2003, 90(Supp 1):S49-S52.
47. Priotto G., Pinoges L., Fursa I.B., Burke B., Nicolay N., Grillet G., et al. Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study. Br Med J 2008, 336:705-708.
48. Kennedy P.G.E. Human African trypanosomiasis of the CNS: current issues and challenges. J Clin Invest 2004, 113:496-504.
49. Checchi F., Piola P., Ayikoru H., Thomas F., Legros D., Priotto G. Nifurtimox plus eflornithine for late-stage sleeping sickness in Uganda: a case series. PLoS Negl Trop Dis 2007, 1(2):e64.
50. Croft S.L. Kinetoplastida: new therapeutic strategies. Parasite 2008, 15:522-527.
51. Molyneux D., Ndung'u J., Maudlin I. Controlling sleeping sickness-when will they ever learn?. PLoS Negl Trop Dis 2010, 4(5):e609.
52. Dujardin J.C., González-Pacanowska D., Croft S.L., Olesen O.F., Späth G.F. Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas. Trends Parasitol 2010, 26:395-403.
53. Cho R.J., Campbell M.J., Winzeler E.A., Steinmetz L., Conway A., Wodicka L., et al. A genome-wide transcriptional analysis of the mitotic cell cycle. Mol Cell 1998, 2:65-73.
54. Chu S., DeRisi J., Eisen M., Mulholland J., Botstein D., Brown P.O., et al. The transcriptional program of sporulation in budding yeast. Science 1998, 282:699-705.
55. McCarroll S.A., Murphy C.T., Zou S., Pletcher S.D., Chin C.S., Jan Y.N., et al. Comparing genomic expression patterns across species identifies shared transcriptional profile in aging. Nat Genet 2004, 36:197-204.
56. White K.P., Rifkin S.A., Hurban P., Hogness D.S. Microarray analysis of Drosophila development during metamorphosis. Science 1999, 286:2179-2184.
57. Kasuga T., Townsend J.P., Tian C., Gilbert L.B., Mannhaupt G., Taylor J.W., et al. Long-oligomer microarray profiling in Neurospora crassa reveals the transcriptional program underlying biochemical and physiological events of conidial germination. Nucleic Acids Res 2005, 33:6469-6485.
58. Konstantinopoulos P.A., Spentzos D., Cannistra S.A. Gene-expression profiling in epithelial ovarian cancer. Nat Clin Pract Oncol 2008, 5:577-587.
59. Farber C.R., Lusis A.J. Integrating global gene expression analysis and genetics. Adv Genet 2008, 60:571-601.
60. Murphy N.B., Pelle R. The use of arbitrary primers and the RADES method for the rapid identification of developmentally regulated genes in trypanosomes. Gene 1994, 141:53-61.
61. Liang P., Pardee A. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992, 257:967-971.
62. Sokolov B.P., Prockop D.J. A rapid and simple PCR-based method for isolation of cDNAs from differentially expressed genes. Nucleic Acids Res 1994, 22:4009-4015.
63. Zhang H., Zhang R., Liang P. Differential screening of gene expression difference enriched by differential display. Nucleic Acids Res 1996, 24:2454-2455.
64. McClelland M., Mathieu-Daudé F., Welsh J. RNA fingerprinting and differential display using arbitrarily primed PCR. Trends Genet 1995, 11:242-246.
65. Mathieu-Daudé F., Cheng R., Welsh J., McClelland M. Screening of differentially amplified cDNA products from RNA arbitrarily primed PCR fingerprints using single strand conformation polymorphism (SSCP) gels. Nucleic Acids Res 1996, 24:1504-1507.
66. Pelle R., Murphy N.B. Stage-specific differential polyadenylation of mini-exon derived RNA in African trypanosomes. Mol Biochem Parasitol 1993, 59:277-286.
67. Mathieu-Daudé F., Welsh J., Davis C., McClelland M. Differentially expressed genes in the Trypanosoma brucei life cycle identified by RNA fingerprinting. Mol Biochem Parasitol 1998, 92:15-28.
68. Matthews K.R., Gull K. Identification of stage-regulated and differentiation-enriched transcripts during transformation of the African trypanosome from its bloodstream to procyclic forms. Mol Biochem Parasitol 1998, 95:81-95.
69. Baptista C.S., Vencio R.Z., Abdala S., Valadares M.P., Martins C., de Braganca Pereira C.A., et al. DNA microarrays for comparative genomics and analysis of gene expression in Trypanosoma cruzi. Mol Biochem Parasitol 2004, 138:183-194.
70. Duncan R. DNA microarray analysis of protozoan parasite gene expression: outcomes correlate with mechanisms of regulation. Trends Parasitol 2004, 20:211-215.
71. Diehl S., Diehl F., El-Sayed N.M., Clayton C., Hoheisel J.D. Analysis of stage specific gene expression in the bloodstream and the procyclic form of Trypanosoma brucei using a genomic DNA-microarray. Mol Biochem Parasitol 2002, 123:115-123.
72. Brems S., Guilbride D.L., Gundlesdodjir-Planck D., Busold C., Luu V.D., Schanne M., et al. The transcriptomes of Trypanosoma brucei Lister 427 and TREU927 bloodstream and procyclic trypomastigotes. Mol Biochem Parasitol 2005, 139:163-172.
73. Koumandou V.L., Natesan S.K., Sergeenko T., Field M.C. The trypanosome transcriptome is remodelled during differentiation but displays limited responsiveness within life stages. BMC Genomics 2008, 9:298.
74. Kabani S., Fenn K., Ross A., Ivens A., Smith T.K., Ghazal P., et al. Genome-wide expression profiling of in vivo-derived bloodstream parasite stages and dynamic analysis of mRNA alterations during synchronous differentiation in Trypanosoma brucei. BMC Genomics 2009, 10:427.
75. Queiroz R., Benz C., Fellenberg K., Hoheisel J.D., Clayton C. Transcriptome analysis of differentiating trypanosomes reveals the existence of multiple post-transcriptional regulons. BMC Genomics 2009, 10:495.
76. Simo G., Herder S., Cuny C., Hoheisel J. Identification of subspecies specific genes differentially expressed in procyclic forms of Trypanosoma brucei subspecies. Infect Genet Evol 2010, 10:229-237.
77. Veitch N.J., Johnson P.C., Trivedi U., Terry S., Wildridge D., MacLeod A. Digital gene expression analysis of two life cycle stages of the human-infective parasite. Trypanosoma brucei gambiense reveals differentially expressed clusters of co-regulated genes. BMC Genomics 2010, 11:124.
78. Casneuf T., Van de Peer Y., Huber W. In situ analysis of cross-hybridisation on microarrays and the inference of expression correlation. BMC Bioinformatics 2007, 8:461.
79. Siegel T.N., Hekstra D.R., Wang X., Dewell S., Cross G.A. Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. Nucleic Acids Res 2010, 38:4946-4957.
80. Kolev N.G., Franklin J.B., Carmi S., Shi H., Michaeli S., Tschudi C. The transcriptome of the human pathogen Trypanosoma brucei at single-nucleotide resolution. PLoS Pathog 2010, 6:e1001090.
81. Faulkner S.D., Oli M.W., Kieft R., Cotlin L., Widener J., Shiflett A., et al. In vitro generation of human high-density-lipoprotein-resistant Trypanosoma brucei brucei. Eukaryot Cell 2006, 5:1276-1286.
82. Nystrom J., Fierlbeck W., Granqvist A., Kulak S.C., Ballermann B.J. A human glomerular SAGE transcriptome database. BMC Nephrol 2009, 10:13-20.
83. Velculescu V.E., Zhang L., Vogelstein B., Kinzler K.W. Serial analysis of gene expression. Science 1995, 270:484-487.
84. Anisimov S.V. Serial Analysis of Gene Expression (SAGE): 13years of application in research. Curr Pharm Biotechnol 2008, 9:338-350.
85. Ersfeld K., Docherty R., Alsford S., Gull K. A fluorescence in situ hybridisation study of the regulation of histone mRNA levels during the cell cycle of Trypanosoma brucei. Mol Biochem Parasitol 1996, 81:201-209.
86. Bringaud F., Baltz T. Differential regulation of two distinct families of glucose transporter genes in Trypanosoma brucei. Mol Cell Biol 1993, 13:1146-1154.
87. Gibson W.C., Swinkels B.W., Borst P. Post-transcriptional control of the differential expression of phosphoglycerate kinase genes in Trypanosoma brucei. J Mol Biol 1988, 201:315-325.
88. Hug M., Carruthers V.B., Hartmann C., Sherman D.S., Cross G.A., Clayton C. A possible role for the 3'-untranslated region in developmental regulation in Trypanosoma brucei. Mol Biochem Parasitol 1993, 61:87-95.
89. Pays E., Hanocq-Quertier J., Hanocq F., van Assel S., Nolan D., Rolin S. Abrupt RNA changes precede the first cell division during the differentiation of Trypanosoma brucei bloodstream forms into procyclic forms in vitro. Mol Biochem Parasitol 1993, 61:107-114.
90. Mayho M., Fenn K., Craddy P., Crosthwaite S., Matthews K. Posttranscriptional control of nuclear-encoded cytochrome oxidase subunits in Trypanosoma brucei: evidence for genome-wide conservation of lifecycle stage-specific regulatory elements. Nucleic Acids Res 2006, 34:5312-5324.
91. El-Sayed N.M., Hegde P., Quackenbush J., Melville S.E., Donelson J.E. The African trypanosome genome. Int J Parasitol 2000, 30:329-345.
92. Chaudhuri M., Hill G.C. Cloning, sequencing, and functional activity of the Trypanosoma brucei brucei alternative oxidase. Mol Biochem Parasitol 1996, 83:125-129.
93. Blattner J., Clayton E. The 3'-untranslated regions from the Trypanosoma brucei phosphoglycerate kinase-encoding genes mediated developmental regulation. Gene 1995, 162:153-156.
94. Taylor J.E., Rudenko G. Switching trypanosome coats: what''s in the wardrobe?. Trends Genet 2006, 22:614-620.
95. Vanhamme L., Lecordier L., Pays E. Control and function of the bloodstream variant surface glycoprotein expression sites in Trypanosoma brucei. Int J Parasitol 2001, 31:523-531.
96. Stockdale C., Swiderski M.R., Barry J.D., McCulloch R. Antigenic variation in Trypanosoma brucei: joining the DOTs. PLoS Biol 2008, 6:e185.
97. Carrington M., Bülow R., Reinke H., Overath P. Sequence and expression of the glycosyl-phosphatidylinositol-specific phospholipase C of Trypanosoma brucei. Mol Biochem Parasitol 1989, 33:289-296.
98. Ziegelbauer K., Multhaup G., Overath P. Molecular characterisation of two invariant surface glycoproteins specific for the bloodstream stage of Trypanosoma brucei. J Biol Chem 1992, 267:10797-10803.
99. Vertommen D., Van Roy J., Szikora J.P., Rider M.H., Michels P.A., Opperdoes F.R. Differential expression of glycosomal and mitochondrial proteins in the two major life-cycle stages of Trypanosoma brucei. Mol Biochem Parasitol 2008, 158:189-201.
100. Jackson D.G., Smith D.K., Luo C., Elliott J.F. Cloning of a novel surface antigen from the insect stages of Trypanosoma brucei by expression in COS cells. J Biol Chem 1993, 268:1894-1900.
101. Berberof M., Pays A., Lips S., Tebabi P., Pays E. Characterization of a transcription terminator of the procyclin PARP A unit of Trypanosoma brucei. Mol Cell Biol 1996, 16:914-924.
102. Coustou V., Biran M., Breton M., Guegan F., Riviere L., Plazolles N., et al. Glucose-induced remodeling of intermediary and energy metabolism in procyclic Trypanosoma brucei. J Biol Chem 2008, 283:16342-16354.
103. Robles A., Clayton C. Regulation of an amino acid transporter mRNA in Trypanosoma brucei. Mol Biochem Parasitol 2008, 157:102-106.
104. Jackson A.P., Sanders M., Berry A., McQuillan J., Aslett M.A., Quail M.A., et al. The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis. PLoS Negl Trop Dis 2010, 4:e658.
105. Vanhollebeke B., De Muylder G., Nielsen M.J., Pays A., Tebabi P., Dieu M., et al. A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans. Science 2008, 320:677-681.
106. Crowther G.J., Shanmugam D., Carmona S.J., Doyle M.A., Hertz-Fowler C., Berriman M., et al. Identification of attractive drug targets in neglected-disease pathogens using an in silico approach. PLoS Negl Trop Dis 2010, 4:e804.
107. Amin D.N., Rottenberg M.E., Thomsen A.R., Mumba D., Fenger C., Kristensson K., et al. Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis. J Infect Dis 2009, 200:1556-1565.
108. Amin D.N., Ngoyi D.M., Nhkwachi G.M., Palomba M., Rottenberg M., Büscher P., et al. Identification of stage biomarkers for human African trypanosomiasis. Am J Trop Med Hyg 2010, 82:983-990.
109. Saas J., Ziegelbauer K., Von Haeseler A., Fast B., Boshart M. A developmentally regulated aconitase related to iron-regulatory protein-1 is localized in the cytoplasm and in the mitochondrion of Trypanosoma brucei. J Biol Chem 2000, 275:2745-2755.
110. Holzmuller P., Grébaut P., Brizard J.P., Berthier D., Chantal I., Bossard G., et al. "Pathogeno-Proteomics": toward a new approach of host-vector-pathogen interactions. Ann NY Acad Sci 2008, 1149:66-70.
111. Holzmuller P., Grébaut P., Cuny G., Biron D.G. Tsetse flies, trypanosomes, humans and animals: what is proteomics revealing about their crosstalks?. Expert Rev Proteomics 2010, 7:113-126.
112. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
113. Matsudaira P.T. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 1987, 262:10035-10038.
114. Anderson N.L., Parish N.M., Richardson J.P., Pearson T.W. Comparison of African trypanosomes of different antigenic phenotypes, subspecies and life cycle stages by two-dimensional gel electrophoresis. Mol Biochem Parasitol 1985, 16:299-314.
115. Shapiro S.Z., Kimmel B.E. Differential protein synthesis during the life cycle of the protozoan parasite Trypanosoma brucei. J Protozool 1987, 34:58-62.
116. Van Deursen F.J., Thornton D.J., Matthews K.R. A reproducible protocol for analysis of the proteome of Trypanosoma brucei by 2-dimensional gel electrophoresis. Mol Biochem Parasitol 2003, 128:107-110.
117. Bridges D.J., Pitt A.R., Hanrahan O., Brennan K., Voorheis H.P., Herzyk P., et al. Characterisation of the plasma membrane subproteome of bloodstream form Trypanosoma brucei. Proteomics 2008, 8:83-99.
118. Colasante C., Ellis M., Ruppert T., Voncken F. Comparative proteomics of glycosomes from bloodstream form and procyclic culture form Trypanosoma brucei brucei. Proteomics 2006, 6:3275-3293.
119. Holzmuller P., Biron D.G., Courtois P., Koffi M., Bras-Gonçalves R., Daulouède S., et al. Virulence and pathogenicity patterns of Trypanosoma brucei gambiense field isolates in experimentally infected mouse: differences in host immune response modulation by secretome and proteomics. Microbes Infect 2008, 10:79-86.
120. Atyame Nten C.M., Sommerer N., Rofidal V., Hirtz C., Rossignol M., Cuny G., et al. Excreted/secreted proteins from trypanosome procyclic strains. J Biomed Biotechnol 2010, 2010:212817.
121. Geiger A., Hirtz C., Bécue T., Bellard E., Centeno D., Gargani D., et al. Exocytosis and protein secretion in Trypanosoma. BMC Microbiol 2010, 10:20.
122. Hart S.R., Lau K.W., Hao Z., Broadhead R., Portman N., Hühmer A., et al. Analysis of the trypanosome flagellar proteome using a combined electron transfer/collisionally activated dissociation strategy. J Am Soc Mass Spectrom 2009, 20:167-175.
123. Degrasse J.A., Chait B.T., Field M.C., Rout M.P. High-yield isolation and subcellular proteomic characterization of nuclear and subnuclear structures from trypanosomes. Methods Mol Biol 2008, 463:77-92.
124. Panigrahi A.K., Ogata Y., Zíková A., Anupama A., Dalley R.A., Acestor N., et al. A comprehensive analysis of Trypanosoma brucei mitochondrial proteome. Proteomics 2009, 9:434-450.
125. Parsons M., Nielsen B. Trypanosoma brucei: two-dimensional gel analysis of the major glycosomal proteins during the life cycle. Exp Parasitol 1990, 70:276-285.
126. Foucher A.L., McIntosh A., Douce G., Wastling J., Tait A., Turner C.M. A proteomic analysis of arsenical drug resistance in Trypanosoma brucei. Proteomics 2006, 6:2726-2732.
127. Nett I.R., Martin D.M., Miranda-Saavedra D., Lamont D., Barber J.D., Mehlert A., et al. The phosphoproteome of bloodstream form Trypanonosoma brucei, causative agent of African sleeping sickness. Mol Cell Proteomics 2009, 8:1527-1538.
128. Jenni L., Molyneux D.H., Livesey J.L., Galun R. Feeding behavior of tsetse flies infected with salivarian trypanosomes. Nature 1980, 283:383-385.
129. Aksoy S., Gibson W.C., Lehane M.J. Interactions between tsetse and trypanosomes with implications for the control of trypanosomiasis. Adv Parasitol 2003, 53:1-83.
130. Munks R.J., Sant'Anna M.R., Grail W., Gibson W., Igglesden T., Yoshiyama M., et al. Antioxidant gene expression in the blood-feeding fly Glossina morsitans morsitans. Insect Mol Biol 2005, 14:483-491.
131. Hu C.Y., Aksoy S. Innate immune responses regulate trypanosome parasite infection of the tsetse fly Glossina morsitans morsitans. Mol Microbiol 2006, 60:1194-1204.
132. Chandra M., Liniger M., Tetley L., Roditi I., Barry J.D. TsetseEP, a gut protein from the tsetse Glossina morsitans, is related to a major surface glycoprotein of trypanosomes transmitted by the fly and to the products of a Drosophila gene family. Insect Biochem Mol Biol 2004, 3:1163-1173.
133. Güther M.L., Lee S., Tetley L., Acosta-Serrano A., Ferguson M.A. GPI-anchored proteins and free GPI glycolipids of procyclic form Trypanosoma brucei are nonessential for growth, are required for colonization of the tsetse fly, and are not the only components of the surface coat. Mol Biol Cell 2006, 17:5265-5274.
134. Acosta-Serrano A., Cole R.N., Mehlert A., Lee M.G., Ferguson M.A., Englund P.T. The procyclin repertoire of Trypanosoma brucei. Identification and structural characterization of the Glu-Pro-rich polypeptides. J Biol Chem 1999, 274:29763-29771.
135. Vassella E., Acosta-Serrano A., Studer E., Lee S.H., Englund P.T., Roditi I. Multiple procyclin isoforms are expressed differentially during the development of insect forms of Trypanosoma brucei. J Mol Biol 2001, 312:597-607.
136. Acosta-Serrano A., Vassella E., Liniger M., Kunz Renggli C., Brun R., Roditi I., et al. The surface coat of procyclic Trypanosoma brucei: programmed expression and proteolytic cleavage of procyclin in the tsetse fly. Proc Natl Acad Sci USA 2001, 98:1513-1518.
137. Bütikofer P., Greganova E., Liu Y.C., Edwards I.J., Lehane M.J., Acosta-Serrano A. Lipid remodelling of glycosylphosphatidylinositol (GPI) glycoconjugates in procyclic-form trypanosomes: biosynthesis and processing of GPIs revisited. Biochem J 2010, 428:409-418.
138. Clemmens C.S., Morris M.T., Lyda T.A., Acosta-Serrano A., Morris J.C. Trypanosoma brucei AMP-activated kinase subunit homologs influence surface molecule expression. Exp Parasitol 2009, 123:250-257.
139. Güther M.L., Beattie K., Lamont D.J., James J., Prescott A.R., Ferguson M.A. Fate of glycosylphosphatidylinositol (GPI)-less procyclin and characterization of sialylated non-GPI-anchored surface coat molecules of procyclic-form Trypanosoma brucei. Eukaryot Cell 2009, 8:1407-1417.
140. Spoerri I., Chadwick R., Renggli C.K., Matthews K., Roditi I., Burkard G. Role of the stage-regulated nucleoside transporter TbNT10 in differentiation and adenosine uptake in Trypanosoma brucei. Mol Biochem Parasitol 2007, 154:110-114.
141. Dean S., Marchetti R., Kirk K., Matthews K.R. A surface transporter family conveys the trypanosome differentiation signal. Nature 2009, 459:213-217.
142. Mina J.G., Pan S.Y., Wansadhipathi N.K., Bruce C.R., Shams-Eldin H., Schwarz R.T., et al. The Trypanosoma brucei sphingolipid synthase, an essential enzyme and drug target. Mol Biochem Parasitol 2009, 168:16-23.
143. Haddow J.D., Poulis B., Haines L.R., Gooding R.H., Aksoy S., Pearson T.W. Identification of major soluble salivary gland proteins in teneral Glossina morsitans morsitans. Insect Biochem Mol Biol 2002, 32:1045-1053.
144. Hurd H. Manipulation of medically important insect vectors by their parasites. Ann Rev Entomol 2003, 48:141-161.
145. Lefèvre T., Thomas F. Behind the scene, something else is pulling the strings: emphasizing parasitic manipulation in vector-borne diseases. Infect Genet Evol 2008, 8:504-519.
146. Lefèvre T., Thomas F., Ravel S., Patrel D., Renault L., Le Bourligu L., et al. Trypanosoma brucei brucei induces alteration in the head proteome of the tsetse fly vector Glossina palpalis gambiensis. Insect Mol Biol 2007, 16:651-660.
147. Agranoff D., Stich A., Abel P., Krishna S. Proteomic fingerprinting for the diagnosis of human African trypanosomiasis. Trends Parasitol 2005, 21:154-157.
148. Tiberti N., Hainard A., Lejon V., Robin X., Mumba Ngoyi D., Turck N., Matovu E., Enyaru J., Mathu Ndung U.J., Scherl A., Dayon L., Sanchez J.C. Discovery and verification of osteopontin and beta-2-microglobulin as promising markers for staging human African trypanosomiasis. Mol Cell Proteomics 2010, 9:2783-2795.
149. Hainard A., Tiberti N., Robin X., Ngoyi D.M., Matovu E., Enyaru J.C., Müller M., Turck N., Ndung'u J.M., Lejon V., Sanchez J.C. Matrix metalloproteinase-9 and intercellular adhesion molecule 1 are powerful staging markers for human African trypanosomiasis. Trop Med Int Health 2010, 10.1111/j.1365-3156.2010.02642.x.
150. Hainard A., Tiberti N., Robin X., Lejon V., Ngoyi D.M., Matovu E., et al. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients. PLoS Negl Trop Dis 2009, 3:e459.